Clinical Trials Sponsored by Brendan Lee

Total 1970 results

H. Lee Moffitt Cancer Center and Research Institute

Recruiting

The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors

Oropharynx Cancer | Oral Cavity Cancer | Larynx Cancer | Hypopharynx Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics

Lynch Syndrome | Pancreatic Ductal Adenocarcinoma | Chronic Pancreatitis | Pancreatic Cyst | Ataxia Telangiectasia | FAP | Peutz-Jeghers Syndrome | PALB2 Gene Mutation | BRCA Mutation | Fatty Pancreas | Genetic Pancreatic Cancer | Genetic Pancreatitis | Familial Atypical Multiple Mole-Melanoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Not yet recruiting

Wet Heparinized Suction for Abdominal Cancer (EUS Heparin)

Cancer | Cancer of Liver | Cancer of Pancreas | Cancer of Stomach | Cancer of Esophagus

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-free

Smoking | Tobacco Use | Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma

Metastatic Melanoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Hodgkin Lymphoma | Burkitt Lymphoma | Acute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Lymphoplasmacytic Lymphoma | Chronic Myelogenous Leukemia | Prolymphocytic Leukemia | Myeloproliferative Neoplasm | Relapsed Follicular Lymphoma | Relapsed T-Cell Lymphoma and other conditions

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

STRONG Program for Cancer Patients

Gastrointestinal Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML

Myelodysplastic Syndromes | Secondary Acute Myeloid Leukemia

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma

Mesothelioma | Malignant Pleural Mesothelioma

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Use of a Proliferation Saturation Index to Determine Personalized Radiotherapy for HPV + Oropharyngeal Cancers

Oropharyngeal Cancer

United States
Seung-Whan Lee, M.D., Ph.D.

Active, not recruiting

Randomized Comparison of DCB for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease (DCB-SFA)

Catheterization, Peripheral | Popliteal Artery | Angioplasty, Balloon | Femoral Artery

Korea, Republic of
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV Glioma

Glioma of Brain

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Developing and Testing a Spanish-Language Intervention to Reduce Cancer-Related Sleep Disturbance

Sleep Disturbance

United States, Puerto Rico
H. Lee Moffitt Cancer Center and Research Institute

Completed

Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck

Squamous Cell Carcinoma of the Head and Neck

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Feasibility Study for Electroacupuncture for Chemotherapy- Induced Peripheral Neuropathy (CIPN)

Chemotherapy-induced Peripheral Neuropathy

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic Cancer

Pancreatic Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma

Carcinoma, Squamous Cell | Squamous Cell Carcinoma of Skin

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease

Chronic Graft Versus Host Disease

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT

Myelodysplastic Syndromes | Primary Myelofibrosis | Multiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin's Lymphoma | Chronic Myelomonocytic Leukemia | Chronic Myeloid Leukemia | Acute Leukemia in Remission

United States
H. Lee Moffitt Cancer Center and Research Institute

Withdrawn

A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS

Breast Cancer

United States
KYU-SUNG LEE
Furun Medical

Completed

Efficacy and Safety of Extracorporeal Biofeedback

Female Stress Urinary Incontinence

Korea, Republic of
H. Lee Moffitt Cancer Center and Research Institute

Completed

Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer

Carcinoma, Transitional Cell | Bladder Cancer | Urethra Cancer | Ureter Cancer | Renal Pelvis Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Fermented Wheat Germ Extract in Women With Ovarian Cancer

Ovarian Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Withdrawn

Biomarker Correlates of Hypoxia in Metastatic Melanoma

Melanoma | Skin Cancer
YongChan Lee
Otsuka Pharmaceutical Co., Ltd.

Completed

A Study to Evaluate REbamiPide as an Adjuvant Regimen to Heal erosIve Reflux Esophagitis (REPAIR)

Gastroesophageal Reflux

Korea, Republic of, China
H. Lee Moffitt Cancer Center and Research Institute

Completed

Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation

Acute Graft Versus Host Disease

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

The Human Papillomavirus (HPV) Transmission Pilot Study

Human Papillomavirus Infection

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Phase II Trial of Pentostatin and Targeted Busulfan (Pento & tBU)

Hematologic Malignancies

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Evaluation of Patient Functionality and Utility of Web-Based Personal Health History and Risk Assess

Cancer | Cancer Screening Patients | Patient Volunteers

United States
Prof. Stephen Lee

Completed

OCT Evaluation of Early Healing of EPC Capturing (GENOUS) Stent (EGO Study) (EGO)

Coronary Artery Disease

Hong Kong
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Autologous SCT Followed by Dendritic Cell p53 Vaccination in Patients With Limited Stage Small Cell Lung Cancer

Small Cell Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Exercise Prehabilitation for Locoregional Esophageal Cancer

Esophageal Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer

Metastatic Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Biomarker Driven Patient Selection Neoadjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma

Melanoma | Advanced Melanoma | Melanoma Stage IV | Melanoma Stage III

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC

Metastatic Castration-resistant Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Senior Adult Hepatobiliary Prehab Study

Cholangiocarcinoma | Liver Metastases | Hepatobiliary Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC

Nonsmall Cell Lung Cancer | Nonsmall Cell Lung Cancer Stage III | Unresectable Non-Small Cell Lung Carcinoma | Nonsmall Cell Lung Cancer, Stage II

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC

Non Small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Recurrent Non Small Cell Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer

Adenocarcinoma of Lung | Lung; Node

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer

Triple Negative Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients (STRONG-GEC)

GastroEsophageal Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Merkel Cell Carcinoma | Cutaneous Melanoma | Cutaneous Squamous Cell Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Preop fSRS for Resectable Brain Metastases

Brain Metastases | Brain Lesion

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies

Surgical Wound Infection

United States
H. Lee Moffitt Cancer Center and Research Institute

Not yet recruiting

Intermittent Fasting for Pancreatitis (IFPanc)

Pancreatitis | Pancreatitis, Chronic | Pancreatitis, Acute | Pancreas Disease | Acute Recurrent Pancreatitis

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy

Follicular Lymphoma | Primary Mediastinal Large B-Cell Lymphoma (PMBCL) | Diffuse Large-Cell Lymphoma | Transformed Follicular Lymphoma (TFL) | High-grade B-cell Lymphoma (HGBCL)

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Generating Novel Therapeutic Strategies Based on Evolutionary Tumor Board

Incurable Disease

United States
H. Lee Moffitt Cancer Center and Research Institute

Not yet recruiting

Modifying Diet to Improve Gut Microbiome

Obesity

United States
Ho Sup Lee
Takeda

Recruiting

Ixazomib Maintenance in Patients With Newly Diagnosed Mantle Cell Lymphoma(MCL)

Mantle Cell Lymphoma

Korea, Republic of

Clinical Trials Sponsored by Brendan Lee

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations